Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inoperable Hepatocellular Carcinoma”

31 trials

Showing 20 of 31 results

Large-scale testing (Phase 3)Study completedNCT02029157
What this trial is testing

Double-blind, Placebo-controlled Japanese Phase III Trial of ARQ 197 in Hepatocellular Carcinoma (HCC)

Who this might be right for
Liver Cancer
Kyowa Kirin Co., Ltd. 386
Not applicableUnknownNCT04730388
What this trial is testing

ATEZOLIZUMAB - BEVACIZUMAB in the Treatment Hepatocellular Carcinoma Inoperable or

Who this might be right for
Advanced Hepatocellular Carcinoma
University Hospital, Brest 100
Not applicableStudy completedNCT01556490
What this trial is testing

Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer

Who this might be right for
Unresectable Hepatocellular Carcinoma
Boston Scientific Corporation 526
Testing effectiveness (Phase 2)Study completedNCT00635323
What this trial is testing

Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Pfizer 73
Testing effectiveness (Phase 2)WithdrawnNCT05157451
What this trial is testing

Y-90 Versus SBRT for Inoperable HCC

Who this might be right for
Hepatocellular CarcinomaStage I Hepatocellular Carcinoma AJCC v8Stage IA Hepatocellular Carcinoma AJCC v8+6 more
OHSU Knight Cancer Institute
Large-scale testing (Phase 3)Study completedNCT01755767
What this trial is testing

Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior Therapy

Who this might be right for
Hepatocellular Carcinoma
Daiichi Sankyo 383
Testing effectiveness (Phase 2)Study completedNCT01835223
What this trial is testing

Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Adult Hepatocellular CarcinomaNon-Resectable Hepatocellular Carcinoma
Roswell Park Cancer Institute 33
Testing effectiveness (Phase 2)Study completedNCT03230318
What this trial is testing

Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic CholangiocarcinomaCombined Hepatocellular and Cholangiocarcinoma
Basilea Pharmaceutica 148
Testing effectiveness (Phase 2)Study completedNCT00287222
What this trial is testing

Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University of Arkansas 21
Testing effectiveness (Phase 2)Study completedNCT01126645
What this trial is testing

Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
University of Magdeburg 529
Not applicableUnknownNCT01850316
What this trial is testing

Hepatocellular Carcinoma Using Stereotactic Body Radiotherapy

Who this might be right for
Hepatocellular Carcinoma
British Columbia Cancer Agency 13
Early research (Phase 1)UnknownNCT02403544
What this trial is testing

Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Chinese Academy of Medical Sciences 30
Large-scale testing (Phase 3)Ended earlyNCT01887717
What this trial is testing

Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein

Who this might be right for
Hepatocellular Carcinoma
Boston Scientific Corporation 36
Testing effectiveness (Phase 2)Study completedNCT02229071
What this trial is testing

Safety and Efficacy of Donafenib in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
HCC
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 106
Large-scale testing (Phase 3)Study completedNCT00003424
What this trial is testing

Tamoxifen in Treating Patients With Primary Liver Cancer

Who this might be right for
Liver Cancer
National Medical Research Council (NMRC), Singapore 300
Testing effectiveness (Phase 2)UnknownNCT05971199
What this trial is testing

Phase II Study of Fruquintinib Combined With Sintilimab and TACE for Inoperable Primary Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhejiang Cancer Hospital 27
Testing effectiveness (Phase 2)Study completedNCT00247676
What this trial is testing

An International Phase 2 Study Of SU011248 In Patients With Inoperable Liver Cancer

Who this might be right for
Liver NeoplasmsUnresectable Hepatocellular Carcinoma
Pfizer 37
Testing effectiveness (Phase 2)Study completedNCT00508001
What this trial is testing

Phase II Study of Best Support Care (BSC) Plus ZD6474(Vandetanib) in Patients With Inoperable Hepatocellular Carcinoma (HCC)

Who this might be right for
Carcinoma, Hepatocellular
Genzyme, a Sanofi Company 67
Testing effectiveness (Phase 2)Study completedNCT00872014
What this trial is testing

The Effectiveness and Safety of AMG 386 and Sorafenib to Treat Advanced or Inoperable Hepatocellular Cancer

Who this might be right for
Advanced Hepatocellular CarcinomaInoperable Hepatocellular Carcinoma
Amgen 60
Testing effectiveness (Phase 2)UnknownNCT04913480
What this trial is testing

SBRT and Durvalumab for Inoperable/Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
The University of Hong Kong 37
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation